## 

|ANNUAL<br>REPORT CONTENTS|||
|---|---|---|
|TRUSTEES' REPORT INCORPORATING|THE STRATEGIC REVIEW||
|STRATEGIC REVIEW.|||
|FINANCIAL<br>REVIEW .|||
|RISKASSESSMENT AND MANAGEMENT.|||
|STRUCTURE, GOVERNANCE<br>AND|MANAGEMENT.|10|
|STATEMENT OF TRUSTEES' RESPONSIBILITIES||.14|
|INDEPENDENT AUDITOR'S REPORT||.15|
|FINANCIAL STATEMENTS||.18|
|REFERENCE AND ADMINISTRATIVE<br>DETAILS||34|





## 

## 

## 

## 



## 

|||||||-|
|---|---|---|---|---|---|---|
|~ ~||||||~<br>~|
|Continue|the||growth|||During the last financial<br>year scientists<br>at El published<br>119publications<br>and shared 24|
|and development|||||of|technical<br>products<br>(webtool/application/software)<br>with<br>the wider scientific<br>community.|
|our world|leading|||||Our<br>scientists<br>also<br>delivered<br>23 oral<br>presentations<br>at<br>national<br>and<br>international|
|investigator-led||||||conferences.<br>The diversity<br>of our funding<br>portfolio has expanded<br>with funding<br>received|
|research|program,|||||from Wellcome,<br>MRC and NERC in addition<br>to BBSRC.|
|continue|to|publish|||||
|high quality||scientific|||||
|outputs,|and||diversify||||
|our income||streams.|||||
|Build strong<br>industrial<br>collaborations<br>so<br>that we are aligned||||||El's expertise<br>in bioinformatics<br>and genomics<br>is one of the seven technology<br>families<br>recognised<br>with the Government<br>strategy.<br>El has demonstrated<br>its impact via its public<br>affairs<br>works,<br>both<br>during<br>the COVID pandemic<br>as well as by engaging<br>with those<br>involved<br>in drafting<br>the proposed<br>gene editing legislation.|
|to the||||||We managed<br>15projects with 17 industrial<br>partners<br>funded<br>by: UKRI (BBSRC,EPSRC,|
|Government's||||||Innovate<br>UK, MRC), Home<br>Office, Royal Academy<br>of Engineering,<br>University<br>of East|
|strategy and so we<br>can achieve impact<br>from our research||||||Anglia,<br>and<br>industry.<br>Our collaborations<br>span<br>plant breeding<br>and agrochemical<br>sector,<br>biotech<br>industry,<br>specialist<br>sequencing<br>and<br>instrumentation<br>companies,<br>data<br>management<br>and bioinformatics<br>companies,<br>and defence and security sector. We have<br>maintained<br>existing, and developed<br>new, relationships<br>with industry<br>through<br>mechanisms|
|||||||such<br>as external<br>engagement<br>events,<br>industry<br>seminar<br>programme<br>and<br>joint<br>PhD|
|||||||studentships.<br>Our industry<br>facing event El Innovate<br>2021 attracted 211 attendees<br>from|
|||||||85 different organisations,<br>among those 173external<br>participants<br>and generated<br>16new|
|||||||connections<br>with<br>industry<br>and academia,<br>leading<br>to 6 new collaborations<br>with<br>industry.|
|||||||The event showcased<br>collaborations<br>across 3 institutes<br>on the Norwich<br>Research Park:|
|||||||Earlham<br>Institute,<br>John Innes Centre, and Quadram<br>Institute.|
|||||||Projects<br>to<br>translate<br>our<br>research<br>and<br>help<br>to<br>realise<br>societal,<br>economic<br>and|
|||||||environmental<br>impact,<br>nationally<br>and<br>internationally<br>included:<br>Identification<br>of novel|
|||||||SARS-Cov-2 lineages<br>from<br>mixed wastewater<br>samples;<br>Quantifying<br>the transmission|
|||||||routes ofgastroenteritis<br>in Pakistan<br>and developing<br>targeted<br>interventions;<br>Development|
|||||||ofa modular<br>synthetic<br>biology pipeline for the engineering<br>bioactive dyes which can help|
|||||||to reduce environmental<br>impact of the textile dyeing<br>industry;<br>Investigating<br>a new drug|
|||||||target for treatment<br>of schizophrenia<br>with the international<br>Psychiatry<br>Consortium,<br>a E4|
|||||||million<br>collaboration<br>between<br>seven<br>global pharmaceutical<br>companies<br>and two leading|
|||||||research charities; and delivering<br>standards<br>for data-driven<br>bioscience.|
|||||||We conducted<br>the assessment<br>of socio-economic<br>impact of the Earlham<br>Institute<br>for|
|||||||2019-2021 which<br>resulted<br>in a forecast<br>contribution<br>of circa F4 billion<br>to the global|
|||||||economy over the next 10years, with return<br>on investment<br>614for every F1 invested.|
|Strengthen||our||||Work continues<br>through<br>our collaboration<br>with<br>WorldFish<br>which<br>aims<br>to accelerate|
|partnerships|||through|||selective breeding oftilapia<br>in the Lake Victoria Basin catchment<br>working<br>with institutions|
|collaboration||||with||based<br>in Kenya, Tanzania<br>and Uganda.<br>From 2021 El is a partner<br>in the WorldFish|
|world leading||||||CGIAR<br>Research<br>Programme,<br>delivering<br>high<br>quality<br>genomic<br>resources<br>and|
|institutes|and|||||contributing<br>to the characterisation<br>ofthe genomic bases ofaquaculture<br>traits. WorldFish|
|scientists|that|||align||is proposed as a core partner<br>in the new Institute strategic programme<br>grant,<br>iffunded to|
|with our|scientific|||||commence<br>from April 2023. The UKRI GCRF GastroPak<br>project continues<br>(2021- end|
|strategy.||||||2023) through<br>which<br>El is leading<br>a partnership<br>with<br>institutes<br>in Pakistan<br>(National|
|||||||University<br>of Sciences<br>& Technology<br>in Islamabad<br>and<br>the<br>University<br>of Agriculture|
|||||||Faisalabad),<br>the<br>National<br>University<br>of Galway<br>and<br>other<br>UK<br>institutes.<br>This<br>a|
|||||||multidisciplinary<br>project to quantify<br>the transmission<br>routes ofgastroenteritis<br>in Pakistan|
|||||||and develop targeted<br>interventions.|





## 

|||||'.|
|---|---|---|---|---|
|~ ~||||~ <br>~|
|Continue to||||We have used our website<br>and social media to run campaigns<br>to highlight<br>our new|
|communicate|our|||vision, mission and strategy which were well received<br>by our stakeholders.<br>Alongside|
|science through||our||this, we have had a focus on communicating<br>our impact,<br>particularly<br>with pieces on|
|public engagement||||aquaculture<br>and<br>wheat<br>that demonstrate<br>our contribution<br>in these<br>key areas<br>of|
|program to a wide||||research.|
|audience,<br>promoting|||the|We attended<br>the<br>Royal Society Summer<br>Showcase,<br>a virtual<br>event<br>that saw us|
|importance<br>of|publicly|||produce<br>a short<br>documentary<br>on the<br>plight<br>of pollinators<br>and<br>an<br>online<br>game|
|funded research||to the||showcasing<br>our research<br>on bees. Feedback was extremely<br>positive and led to the|
|general public.||||Royal Society asking<br>us to feature the Bee Trail at the European<br>Science Festival,|
|||||organised<br>by the Slovenian<br>Science Foundation.|
|||||Our Barcoding the Broads outreach<br>work trained over 100people<br>in DNA barcoding,|
|||||reaching<br>teachers,<br>technicians,<br>students,<br>naturalists<br>and<br>local<br>artists.<br>We also|
|||||received funding<br>for ajoint project with Kew Gardens and a local nature group to look|
|||||at fungi. We also secured an invitation<br>to exhibit the Darwin Tree of Life project at the|
|||||2022 Royal Society Summer Science Exhibition<br>with Wellcome Sanger Institute.|
|||||We also started a project to rebuild our website, with a launch<br>in early 2022/23 to help|
|||||us ensure<br>it is fitfor the future, remains secure, meets accessibility<br>requirements,<br>and|
|||||gives visitors the best possible user experience.|



## 



## 

## 

## 

## 

## 

## 



## 

||||||||||||~<br>~<br>~||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||~I|0||||||||||||||||||||
||||||||||~||||||||||||||||
|~|||~ ~||~||||||||||||||||||||
||||||||||||& El<br>is<br>unable||to||keep||||pace||with|& Bidding<br>into Capital<br>Grant|opportunities<br>to||
||||||||||||developments|in|technology|||||underpinning||||refresh<br>platforms.|||
||||||||||||its science.|||||||||||&Technology<br>strategy<br>kept|under|regular|
||||||||||||& Funding<br>and/or|||cost|||recoveries||||are|review and funding<br>opportunities||identified|
||||||||||||inadequate<br>to<br>sustain<br>and<br>technology<br>facilities<br>necessary<br>to <br>scientific objectives.|||||||||improve<br> support||and pursued<br>for technology<br>investments.<br>& El has<br>reserves<br>that<br>enable<br>it to move<br>quickly<br>when<br>technology<br>enhancements|||
|||||||||||||||||||||||become available.|||
||||||||||||& El is not able to||access||||EU||programme|||& Regular dialogue<br>with<br>UKRI - BBSRCand|||
||||||||||||funding<br>or|participate|||||in|EU||research||other<br>key<br>stakeholders|on<br>risks<br>and||
||||||||||||collaborations.|||||||||||emerging<br>issues<br>with respect to||potential|
||||||||||||& El is not able to recruit||||or|retain|||researchers|||changes<br>in arrangements.|||
||||||||||||from EU member||countries.|||||||||& Kept abreast of risks and|potential<br>impact||
||||||||||||& El<br>is<br>not<br>international<br>Government|able<br>to<br>continue<br>with<br>its<br>funding<br>programmes<br>due to<br>Overseas<br>Development<br>Aid||||||||||from staff leaving<br>El/UK,<br>and ensure<br>we<br>prepare<br>for the new immigration<br>and visa<br>process post BREXIT.|||
||||||||||||budgets cuts.|||||||||||& Realign<br>overseas<br>programmes||into<br>new|
|||||||||||||||||||||||and evolving<br>funding<br>programmes||as they|
|||||||||||||||||||||||arise.|||
|||~|~||||||||||||||||||||||
||||~|~||~||~||~|||||||||||||||
||~|~|||~||~||~||||||||||||||||
||~|~|||||||||& El<br>fails<br>to|comply|||with|||sponsor|||grant|& El is subject to regular<br>reviews of its grant|||
||~ ~||~||~||~||||requirements|resulting|||||in||a|material||compliance<br>processes<br>from sponsors<br>and|||
||||||||||||financial<br>impact.|||||||||||the<br>Research<br>Councils|UK|internal|
|||||||||||||||||||||||auditors.|||





|||||||||~|~|~||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||~|||~|~|~||||||||||||||
|~|~|~||||||||||||||||||
||||~||~||&|Risking||energy||prices|mean|that|current||& El to keep funders abreast|of rising energy||
|||||||||funding||levels,||and|business|plan||are|costs, and look for funding|opportunities|to|
|||||||||unsustainable|||long term.||||||assist<br>with<br>rising costs of|delivering<br>core||
||||||||||||||||||programmes.|||
||||||||||||||||||& El to increase energy usage|monitoring<br>and||
||||||||||||||||||reporting<br>to enable<br>it to review<br>its energy|||
||||||||||||||||||consumption<br>and operational<br>practices||to|
||||||||||||||||||ensure best energy efficiency.|||
||||||||||||||||||& El to continue<br>to buy energy<br>at the best|||
||||||||||||||||||price via working<br>with others on the NRP||to|
||||||||||||||||||secure future energy prices|at best value.||





## 

## 

## 

## 

|At date ofReport:||||||
|---|---|---|---|---|---|
|Professor Peter Holland|(Chair)||Rem Com|||
|Dr Alasdair Macnab|||AC (Chair), Rem Com (Chair)|||
|Professor Thomas Richards||||||
|Ms Amanda<br>Tagg|||AC, Rem Com|||
|Professor Edward<br>Louis|||AC (up to 12October 2021)|||
|Professor Philip Gilmartin|||AC (from 12October 2021)|||
|Professor Deborah<br>Smith|||Rem Com (from 7 December 2021)|Appointed|7 December 2021|
|Dr Lars Magnus<br>Rattray||||Appointed|21 June 2022|
|Dr Stephanie Joan Pilkington||||Appointed|21 June 2022|
|During the year:||||||
|Professor Dame Janet Thornton||(Chair)||Resigned|29 March 2022|
|Mrs Andrea Finegan|||AC, Rem Com (Chair)|Resigned|21 June 2022|
|Professor Jean Beggs|||Rem Com|Resigned|7 December 2021|



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 



## 

## 

## 

||||||Unrestricted|Restricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
||||||funds|funds|capital|2022|2021|
|||||Note|f000|f000|f000|f000|f000|
|Income||||||||||
|Income from charitable|activities|||||||||
|Grant Income - BBSRC||||||8,668||8,668|8,466|
|Grant Income - other||||||1,580||1,580|566|
|Other Research Income|||||860|||860|386|
|Capital funding<br>—BBSRC||||||126|2,535|2,661|1,192|
|Income from other trading||activities||||||||
|Trading<br>income|||||293|||293|409|
|Rental income|||||26|||26|26|
|Investment<br>income||||10|47|||47|56|
|Other generated income|||||126|||126|43|
|Total income||||2|1,352|10,374|2,535|14,261|11,144|
|Expenditure||||||||||
|Charitable<br>activities||||3|(1,056)|(9,673)|(2,459)|(13,188)|(12,307)|
|Raising funds|||||(115)|-|-|(115)|(122)|
|Trading expenditure|||||(103)|||(103)|(83)|
|Total ex<br>nditure|||||1,274|9,673|2,459|13,406|12,512|
|Net incomel ex enditure||for the|ear||78|701|76|855|1,368|
|Other transfers||||20|(359)|359||||
|Capital transfers||||20|901|(400)|(501)|||
|Net movement<br>in funds|||||620|660|425|855|1,368|
|Funds brought forward|||||11,786|1,289|8,546|21,621|22,989|
|Funds carried forward||||20|12,406|1,949|8,121|22 476|21,621|





## 

||||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|---|---|
||||||2022|2021|2022|2021|
|||||Note|OOOO|OOOO|6000|f000|
|Fixed assets|||||||||
|Tangible assets||||11|9,211|9,350|9,211|9,350|
|Intangible<br>assets||||12|||||
|Current assets|||||||||
|Stocks||||14|222|163|222|163|
|Debtors||||15|4,722|3,164|4,578|3,005|
|Cash at bank and in hand||||16|14,667|15,461|14,606|15,329|
||||||19,611|18,788|19,406|18,497|
|Current<br>liabilities|||||||||
|Creditors:<br>amounts||falling|due within one year|17|(6,346)|(6,517)|(6,333)|(6,483)|
|Total net current|assets||||13265|12,271|13073|12,014|
|Total assets less|current||liabilities||22,476|21,621|22,284|21,364|
|Total net assets||||19|22 476|21,621|22 284|21,364|
|The funds ofthe|charity||||||||
|Restricted funds|||||||||
|Fixed asset reserve||||20|8,121|8,546|8,121|8,556|
|Designated<br>reserves||||20|1,625|861|1,625|861|
|General reserve||||20|324|428|324|428|
|Total restricted<br>funds|||||10,070|9,835|10,070|9,845|
|Unrestricted<br>funds|||||||||
|Fixed asset resene||||20|1,090|804|1,090|804|
|Designated<br>reserves||||20|7,382|6,877|7,382|6,877|
|General resene||||20|3,934|4,105|3,742|3,838|
|Total unrestricted|funds||||12,406|11,786|12,214|11,519|
|Total funds|||||22 476|21,621|22 284|21,364|





## 

||||||||||Total|Total|
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||2022|2021|
|||||||||Note|OOOO|OOOO|
|Cash flows from operating|activities:||||||||||
|Operating<br>profit/(deficit)|||||||||855|(1,368)|
|Interest receivable|||||||||(47)|(56)|
|Depreciation<br>and amortisation|||||||||2,459|3,064|
|Capital grants received|||||||||(2,661)|(1,192)|
|Loss on disposal of tangible|assets||||||||20|169|
|Increase<br>in stocks|||||||||(59)|(83)|
|Increase<br>in debtors|||||||||(1,558)|(1,087)|
|(Decrease)/Increase<br>in creditors|||||||||(171)|1,549|
|Net cash (used in) I provided||by|operating|||activities|||(1,162)|996|
|Cash Flows from investing<br>activities:|||||||||||
|Interest received|||||||||47|56|
|Purchase<br>of tangible assets|||||||||(2,349)|(1,728)|
|Capital grants received|||||||||2,661|1,192|
|Proceeds from sale of tangible||assets|||||||9||
|Net cash provided<br>by I (used||in)|investing|||activities|||368|(480)|
|Change<br>in cash and cash|equivalents|||in the reporting|||period||(794)|516|
|Cash and cash equivalents|at the beginning||||of|the period||16|15,461|14,945|
|Total cash and cash equivalents|||at the end ofthe year|||||16|14,667|15,461|





## 

## 

|2.<br>ANALYS|IS|OF INCOMING RES|OURCES||||||
|---|---|---|---|---|---|---|---|---|
||||Research|Other|Total|Research|Other|Total|
||||activities|activities|2022|activities|activities|2021|
||||L'000|L'000|6000|f000|f000|6000|
|Grant income|||||||||
|BBSRC|||8,668||8,668|8,466||8,466|
|Other government|departments||546||546|72||72|
|European<br>Union|||7||7|24||24|
|Universities|||618||618|246||246|
|Other charities|||744||744|396||396|
|Other grants|||525||525|214||214|
|Total<br>rant income|||11,108||11108|9,418||9,418|
|Capital grants|||||||||
|BBSRC|||||||||
|Capital expenditure|||2,661||2,661|1,192||1,192|
|Total ca ital<br>rants|||2,661||2 661|1,192||1,192|
|Trading<br>income|||||||||
|Earlham<br>Enterprises||Ltd||293|293||409|409|
|Rental income||||26|26||26|26|
|Total tradin<br>income||||319|319||435|435|
|Investment<br>income|||||||||
|Interest receivable|on cash deposits|||47|47||56|56|
|Total investment|income|||47|47||56|56|
|Other income|||||||||
|Other income||||126|126||43|43|
|Total other income||||126|126||43|43|
|Total incomin<br>resources|||13,769|492|14261|10,610|534|11,144|





## 

## 

|Expenditure|on|charitable|activities and governance<br>costs have be|en analysed<br>below.|||
|---|---|---|---|---|---|---|
||||||Total|Total|
|Ex enditure|on|charitable|activities||2022|2021|
|||||Note|f000|f000|
|Direct charitable||expenditure:|||||
|Staff costs|||||4,587|4,501|
|Direct costs|||||4,680|3,291|
|Depreciation|||||2,459|3,064|
|Governance|costs||||104|95|
|Support costs||||4|1,358|1,356|
|Total ex enditure|||||13188|12,307|
||||||Total|Total|
|Ana<br>sis of|overnance costs||||2022|2021|
||||||f000|f000|
|Staff costs|||||99|93|
|Other costs|||||5|2|
|Total<br>overnance costs|||||104|95|



## 

|(depreciation)<br>off2,459k (2021:E3,064k).<br>4.<br>ALLOCATION<br>OF SUPPORT|All other expenditure<br> COSTS|is unrestrict|ed.|||||
|---|---|---|---|---|---|---|---|
||Charitable|Raising|Total|Charitable|Raising|Total|Basis of|
||Activities|Funds|2022|Activities|Funds|2021|Allocation|
||FOOO|6000|f000|6000|6000|6000||
|Building services*|477||477|507||507|Activity|
|Finance and Contracts*|190|115|305|196|122|318|Activity|
|Management,<br>ITand Communications*|349||349|328||328|Activity|
|Human<br>Resources and Staff Welfare*|138||138|127||127|Activity|
|Other support services|21|68|89|19|57|76|Activity|
|Total support costs|1,175|183|1,358|1,177|179|1,356||



## 



|Operating<br>surplus<br>is state|d||after c|harging|:|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||||||||Total||Total|
||||||||||||||||||2022||2021|
||||||||||||||||||f000||f000|
|Audit services:||||||||||||||||||||
|Fees for the audit of the charitable||||company||and consolidated||||financial||statements|||||12||12|
|Fees for the audit of the charitable||||company's|||subsidiary||pursuant||to legislation|||||||2|2|
|Non-audit<br>services:||||||||||||||||||||
|Other fees payable to the|auditors<br>of the charitable|||||||company||||||||||||
|Depreciation|||||||||||||||||2,459||3,064|
|Loss on disposal of tangible||assets|||||||||||||||20||169|
|Operating<br>lease rentals<br>(land||and buildings)|||||||||||||||130||101|
|Hire of plant and equipment||||||||||||||||||9|4|
|Loss on foreign exchange|translations|||||||||||||||||7|10|
|7.<br>RESULTS OF TRADING ACTIVITIES|||||||||OF SUBSIDIARY|||||||||||
||||||||||||||||||Total||Total|
|Earlham<br>Enterprises<br>Limited|||||||||||||||||2022<br>f000||2021<br>f000|
|Profit and loss account||||||||||||||||||||
|Turnover|||||||||||||||||293||409|
|Cost ofsales|||||||||||||||||(103)||(153)|
|Gross profit|||||||||||||||||190||256|
|Administrative<br>e<br>enses||||||||||||||||||||
|Operating<br>profit retained|||in subsidiary||||||||||||||190||255|
|Net assets at 31 March|2022||||||||||||||||192||257|
|In addition<br>to the above, f254,745(2021:f135,503)|||||||||in Gift|Aid|was|paid to|the charitable||company|in|the year.|||
|8.<br>REMUNERATION|||OF|MEMBERS||||OF|THE BOARD OF TRUSTEES|||||||||||
|El has been given<br>approval|||by the Charities||||Commission|||to|remunerate||trustees|where|the Board considers<br>that||||payment<br>is|
|necessary to attract trustees|||with|specialist||skills||and|experience.|||The power to remunerate<br>trustees|||||is included|in El's Articles||
|ofAssociation.||||||||||||||||||||
|Seven members<br>of the Board of Trustees||||||received|||remuneration|||from the group||during|the year|for|their duties|as a Trustee||
|(2021:six). Total trustee||remuneration|||in|the year was f28,000 (2021:f29,000).||||||||Details ofthe||remuneration<br>paid|||during<br>the|
|year is as follows:||||||||||||||||||||
||||||||||||||||||Total||Total|
|Name ofTrustee|||||||||||||||||2022||2021|
||||||||||||||||||f000||f000|
|Professor Peter Holland||||||||||||||||||||
|Professor Thomas Richards||||||||||||||||||||
|Professor Dame Janet Thornton||||||||||||||||||||
|Mrs Andrea<br>Finegan||||||||||||||||||||
|Dr Alasdair<br>Macnab||||||||||||||||||||
|Professor<br>Edward<br>Louis||||||||||||||||||||
|Professor Deborah Smith||||||||||||||||||||
|Professor<br>Phili<br>Gilmartin||||||||||||||||||||
|Total|||||||||||||||||32||29|





## 

## 

|The average|monthly|number of persons employed|number of persons employed|number of persons employed|by or deployed|by or deployed|to the group, analysed|to the group, analysed|by category,|was|as follows:||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Grou<br>and|charitable||com an||||||||2022|2021|
|||||||||||Number||Number|
|Scientific|||||||||||99|91|
|Office mana|ement and services||||||||||18|17|
|Total|||||||||||117|108|
|The aggregate<br>payroll||costs ofthese persons||were:|||||||||
||||||||||||2022|2021|
||||||||||Note||f000|OOOO|
|Wages and|salaries||||||||||4,278|4,117|
|Redundancy|costs||||||||||4|5|
|Social security costs|||||||||||423|433|
|Other pension costs|||||||||22||644|602|
|Total|||||||||||5,349|5,157|
|As required|by Charites SORP an analysis|||has been provided||below of the number||of staff who fall||within|emoluments|bands|
|from f60,000 upwards.|||||||||||||
|Grou<br>and|charitable||com an||||||||2022|2021|
|||||||||||Number||Number|
|260,000 —F69,999|||||||||||||
|F70,000 - F79,999|||||||||||||
|280,000 —F89,999|||||||||||||
|2100,000 -|F109,999||||||||||||
|2110,000 -|F119,999||||||||||||
|2160,000 —F169,999|||||||||||||
|Total|||||||||||12||





## 

## 

||Total|Total|
|---|---|---|
||2022|2021|
||OOOO|f000|
|Bank interest|45||
|Interest on loans|2||
|Total|47|56|



## 

|11.TANGIBLE|A|SSET|S|||||||
|---|---|---|---|---|---|---|---|---|---|
||||||||Plant,|||
|||||||machinery||Assets||
|||||Leasehold|||and|under||
|Grou<br>and charitable||corn|an|im rovements||e|ui<br>ment|construction|Total|
|||||f000|||f000|OOOO|OOOO|
|Cost||||||||||
|At 1 April 2021||||8,661|||27,191|1,042|36,894|
|Transfers|||||549||469|(1,018)||
|Additions|||||814||1,052|483|2,349|
|Dis osals|||||||2,394|24|2,418|
|At 31 March 2022||||10|024||26318|483|36825|
|Accumulated<br>Depreciation||||||||||
|At 1 April 2021||||5,697|||21,847||27,544|
|Charge for the year|||||256||2,203||2,459|
|Dis osals|||||||2,389||2,389|
|At 31 March 2022||||5|953||21 661||27 614|
|Net book value at|31|March 2022||4|071||4657|483|9211|
|Net book value at 31 March 2021||||2,964|||5,344|1,042|9,350|
|All ofthe charitable|company||assets at 31 March 2022|are used for direct charitable|purposes.|||||



## 

|12. INTANGIBLE ASSETS||||
|---|---|---|---|
||Software|||
|Grou|develo|ment|Total|
|||f000|OOOO|
|Cost||||
|At 1 April 2021||177|177|
|Additions||||
|At 31 March 2022||177|177|
|Accumulated<br>Depreciation||||
|At 1 April 2021||177|177|
|Char efor the<br>ear||||
|At 31 March 2022||177|177|
|Net book value at 31 March 2022||||
|Net book value at 31 March 2021||||





## 


## 

## 

|undertaki|ng<br>in whi|ch the charitable|company<br>has an interest:||||||
|---|---|---|---|---|---|---|---|---|
||||Country of|||Class and percentage||of|
|Subsidia|Undertakin||re istration|Princi|al activit|shares held|||
|Earlham|Enterprises|Limited|England|Contract research||100%ordinary|shares||



## 

||||||Total|Total|
|---|---|---|---|---|---|---|
|Grou|and charitable||corn|an|2022|2021|
||||||f000|OOOO|
|Raw|materials|and consumables|||222|163|
|Total|||||222|163|





## 

## 

||||||||||Group|Group|Company|Company|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||2022|2021|2022|2021|
|||||||||Note|OOOO|OOOO|OOOO|OOOO|
|Grants receivable:|||||||||||||
|from government|bodies||||||||1,651|407|1,651|407|
|from other sources|||||||||875|243|875|243|
|Trade debtors|||||||||458|314|334|70|
|Amounts<br>owed by|subsidiary||undertakings||||||||20|85|
|Amounts<br>owed by|other|related||parties||||23|247|171|247|171|
|Other debtors|||||||||297|73|297|73|
|Pre a ments and|accrued income||||||||1 194|1,956|1 154|1,956|
|Total amounts<br>fallin||due within|||one|ear|||4722|3,164|4578|3,005|
|The above amounts<br>fall||due within|||one year.||||||||
|Grants receivable|from|government|||bodies||includes F427,730 in relation to capital funding|||receivable|from BBSRC|(2021:|
|F75,602).|||||||||||||
|16.<br>CASH|AT|BANK||AND IN|||HAND||||||
||||||||||Group|Group|Company|Company|
||||||||||2022|2021|2022|2021|
||||||||||OOOO|FOOO|OOOO|FOOO|
|Cash at bank|||||||||14667|15,461|14606|15,329|
|Total|||||||||14,667|15,461|14,606|15,329|
|17.<br>CREDITORS: AMOUNTS|||||||FALLING|DUE WITHIN ONE YEAR|||||
||||||||||Group|Group|Company|Company|
||||||||||2022|2021|2022|2021|
|||||||||Note|OOOO|FOOO|OOOO|FOOO|
|Grants received in advance:|||||||||||||
|from government|bodies||||||||695|1,049|695|1,049|
|from other sources|||||||||475|387|475|376|
|Amounts<br>owed to|other|related||parties||||23|214|307|214|307|
|Trade creditors|||||||||1,271|1,216|1,271|1,216|
|Other creditors|||||||||1,666|962|1,653|939|
|Taxation and social security|||||||||105|106|105|106|
|Accruals and deferred||income|||||||1 920|2,490|1 920|2,490|
|Total amounts<br>fallin||due within|||one|ear|||6346|6,517|6333|6,483|
|18.<br>RECONCILIATION|||||OF MOVEMENT|||IN GRANTS RECEIVABLE|||||



|||||||Total|Total|
|---|---|---|---|---|---|---|---|
|Group||||||2022|2021|
||||||Note|F000|f000|
|Grants receivable|||||15|2,526|650|
|Grants received<br>in advance|||||17|(1,170)|(1,436)|
|Net grants receivable|at the end of|the|year i(received|in advance)||1,356|(786)|
|Net grants received<br>in|advance at beginning||of year|||(786)|(884)|
|Grant monies received|during the year|||||(8,106)|(8,934)|
|Grant money released|to SOFA during|the|year|||10,248|9,032|
|Net grants receivable|at the end of|the|year I (received|in advance)||1,356|(786)|





## 

## 

|19.<br>ANALYSIS OF NET ASSETS BETWE|EN FUNDS|||
|---|---|---|---|
|||Net||
||Fixed|current|Total|
||assets|assets|2022|
||f000|f000|OOOO|
|Group||||
|Unrestricted:||||
|Fixed asset reserve|1,090||1,090|
|Designated<br>reserves||7,382|7,382|
|General reserve||3,934|3,934|
|Restricted:||||
|Fixed asset reserve|8,121||8,121|
|Designated<br>reserves||1,625|1,625|
|General reserve||324|324|
|Total net assets|9211|13265|22,476|
|Charitable<br>company||||
|Unrestricted:||||
|Fixed asset reserve|1,090||1,090|
|Designated<br>reserves||7,382|7,382|
|General reserve||3,742|3,742|
|Restricted:||||
|Fixed asset reserve|8,121||8,121|
|Designated<br>reserves||1,625|1,625|
|General reserve||324|324|
|Total net assets|9211|13073|22,284|
|||Net||
||Fixed|current|Total|
||assets|assets|2021|
||f000|FOOO|f000|
|Group||||
|Unrestricted:||||
|Fixed asset reserve|804||804|
|Designated<br>reserves||6,877|6,877|
|General reserve||4,105|4,105|
|Restricted:||||
|Fixed asset reserve|8,546||8,546|
|Designated<br>reserves||861|861|
|General reserve||428|428|
|Total net assets|9350|12271|21 621|
|Charitable<br>company||||
|Unrestricted:||||
|Fixed asset reserve|804||804|
|Designated<br>reserves||6,877|6,877|
|General reserve||3,838|3,838|
|Restricted:||||
|Fixed asset reserve|8,546|10|8,556|
|Designated<br>reserves||861|861|
|General reserve||428|428|
|Total net assets|9350|12014|21 364|





## 

||||Unrestricted||||||Restricted|||
|---|---|---|---|---|---|---|---|---|---|---|---|
||||fixed|Unrestricted||Unrestricted|Restricted||fixed|Restricted|Total|
||||reserve|desi|nated|eneral|desi|nated|reserve|eneral|2022|
||||OOOO||f000|f000||f000|OOOO|f000|f000|
|Group||||||||||||
|At 1 April 2021|||804|6,877||4,105||861|8,546|428|21,621|
|Operating<br>surplus<br>for|the year|||||78|||76|701|855|
|Capital transfers|||182|||29|||(211)|||
|Unrestricted<br>general|capital expenditure||104||(104)|||(526)|400|126||
|Unrestricted<br>designated||transfer|||609|(420)||600||(789)||
|Restricted designated|transfer|||||||690|(690)|||
|Other transfers||||||142||||142||
|At 31 March 2022|||1,090|7,382||3,934||1,625|8,121|324|22,476|
|Charitable<br>company||||||||||||
|At 1 April 2021|||804|6,877||3,838||861|8,556|428|21,364|
|Operating<br>surplus<br>for|the year|||||143|||76|701|920|
|Capital transfers|||182|||29|||(211)|||
|Unrestricted<br>general|capital expenditure||104||(104)|||(526)|400|126||
|Unrestricted<br>designated||transfer|||609|(420)||600||(789)||
|Restricted designated|transfer|||||||690|(690)|||
|Other transfers||||||152|||10|142||
|At 31 March 2022|||1,090|7,382||3,742||1,625|8,121|324|22 284|
||||Unrestricted||||||Restricted|||
||||fixed assets|Unrestricted||Unrestricted|Restricted||fixed|Restricted|Total|
||||reserve|desi|nated|eneral|desi|nated|reserve|eneral|2021|
||||6000||f000|f000||f000|f000|f000|6000|
|Group||||||||||||
|At 1 April 2020|||951||5,572|4,530||1,651|9,904|381|22,989|
|Operating<br>surplus/(deficit)||for the year||||190|||(2,073)|515|(1,368)|
|Capital transfers|||(252)||169||||83|||
|Unrestricted<br>general capital expenditure|||105||(105)|||||||
|Unrestricted<br>designated||transfer|||773|(615)||(158)||||
|Restricted designated|transfer|||||||(632)|632|||
|Other transfers|||||468|||||468||
|At 31 March 2021|||804||6,877|4,105||861|8,546|428|21 621|
|Charitable<br>company||||||||||||
|At 1 April 2020|||||5,572|4,392||1,651|9,914|381|22,851|
|Operating<br>surplus/(deficit)||for the year||||71||-|(2,073)|515|(1,487)|
|Capital transfers|||(242)||169|(10)|||83|||
|Unrestricted<br>general capital expenditure|||105||(105)|||||||
|Unrestricted<br>designated||transfer|||773|(615)||(158)||||
|Restricted designated|transfer|||||||(632)|632|||
|Other transfers|||||468|||||468||
|At 31 March 2021|||804||6,877|3,838||861|8,556|428|21 364|





## 

## 

|||||||Total|Total|
|---|---|---|---|---|---|---|---|
|Grou|and charitable||com an|||2022|2021|
|||||||OOOO|f000|
|Capital|commitments|at|the end of|the financial year for which no provision|has been made:|||
|Contracted||||||992|892|
|||||||Total|Total|
|Grou|and charitable||corn an|||2022|2021|
|||||||OOOO|f000|
|Amounts|due under|other operating||leases for land and buildings:||||
|Under|one year|||||100|100|
|Between one and||five|years|||400|400|
|Over 5<br>ears||||||1 276|1 376|
|||||||1 776|1 876|
|Amounts|due under|other operating||leases for plant and machinery:||||
|Under|one year|||||||
|Between one and||five|years|||||
|Over 5<br>ears||||||||



## 



## 

## 

## 

## 

## 

## 



## 

## 

